|[February 03, 2014]
Biomet Announces Settlement of Multi-District Litigation
WARSAW, Ind. --(Business Wire)--
Biomet, Inc. announces that it has reached a settlement in MDL 2391 - In
Re: Biomet M2A Magnum Hip Implant Products Liability Litigation
related to claims associated with its metal-on-metal hip products
pending in the United States District Court for the Northern District of
Indiana, South Bend Division. Judge Robert L. Miller, Jr. approved the
settlement of the MDL today.
Biomet is pleased to have reached this settlement and have the MDL
resolved. Biomet appreciats the guidance provided by Judge Miller to
bring this litigation to an expeditious and efficient resolution.
Biomet, Inc. and its subsidiaries design, manufacture and market
products used primarily by musculoskeletal medical specialists in both
surgical and non-surgical therapy. Biomet's product portfolio includes
knee and hip reconstructive products; sports medicine, extremities and
trauma products; spine, bone healing and microfixation products,
including spine hardware, spinal stimulation devices, osteobiologics,
and non-invasive bone growth stimulators; as well as neurosurgical and
craniomaxillofacial reconstructive devices, and thoracic products;
dental reconstructive products; and bone cement products, biologics, and
other products. Headquartered in Warsaw, Indiana, Biomet and its
subsidiaries currently distribute products in approximately 90 countries.
[ Back To TMCnet.com's Homepage ]